Prognostic relevance of ventricular arrhythmias in surgical patients with gastrointestinal tumors

Figure 3 Cumulative survival of all patients. A: Cumulative survival of all-cause mortality among patients with gastrointestinal tumors divided by premature ventricular contractions (PVCs) (n = 130); B: Cumulative survival of major adverse cardiovascular events (MACEs) among patients with gastrointestinal tumors divided by PVCs (n = 130); C: Cumulative survival of all-cause mortality among patients with gastrointestinal tumors divided by non-sustained ventricular tachycardia (n = 130); D: Cumulative survival of MACEs among patients with gastrointestinal tumors divided by non-sustained ventricular tachycardia (n = 130). PVC: Premature ventricular contraction; MACE: Major adverse cardiovascular event; NSVT: Non-sustained ventricular tachycardia.